Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective

Respir Med Res. 2020 Nov:78:100781. doi: 10.1016/j.resmer.2020.100781. Epub 2020 Aug 3.

Authors

S John Wort¹, D J Arachchillage², C McCabe¹, L C Price³

Affiliations

¹ National Pulmonary Hypertension Service, Royal Brompton Hospital, London, SW3 6NP, UK; Imperial College London, London, UK.
² Imperial College London, London, UK; Department of Haematology, Royal Brompton Hospital, London, SW3 6NP, UK.
³ National Pulmonary Hypertension Service, Royal Brompton Hospital, London, SW3 6NP, UK; Imperial College London, London, UK. Electronic address: laura.price@rbht.nhs.uk.

No abstract available

Keywords: Coronavirus; ECMO; Guidelines; Intensive care; Pulmonary embolism; Pulmonary hypertension; Royal Brompton Hospital London UK.

Publication types

Editorial

MeSH terms

COVID-19 / complications*
COVID-19 / epidemiology
COVID-19 / therapy
Critical Care / methods
Critical Care / standards
Extracorporeal Membrane Oxygenation / methods
Extracorporeal Membrane Oxygenation / standards
Humans
Hypertension, Pulmonary / epidemiology
Hypertension, Pulmonary / therapy
Hypertension, Pulmonary / virology
Lung Diseases / epidemiology
Lung Diseases / therapy
Lung Diseases / virology*
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy
Practice Guidelines as Topic
Pulmonary Embolism / epidemiology
Pulmonary Embolism / therapy
Pulmonary Embolism / virology
Pulmonary Veno-Occlusive Disease / epidemiology
Pulmonary Veno-Occlusive Disease / etiology
Pulmonary Veno-Occlusive Disease / therapy
SARS-CoV-2 / physiology
United Kingdom / epidemiology
Vascular Diseases / epidemiology
Vascular Diseases / therapy
Vascular Diseases / virology*